Literature DB >> 18230715

The duffy antigen/receptor for chemokines exists in an oligomeric form in living cells and functionally antagonizes CCR5 signaling through hetero-oligomerization.

Aron Chakera1, Ruth M Seeber, Alison E John, Karin A Eidne, David R Greaves.   

Abstract

The Duffy antigen/receptor for chemokines (DARC) is an unusual chemokine receptor that binds a large number of inflammatory chemokines of both the CC and CXC families with nanomolar affinity, yet it lacks the ability to signal upon ligand binding. Using bioluminescent resonant energy transfer, we have demonstrated for the first time that DARC exists as a constitutive homo-oligomer in living cells and furthermore that DARC hetero-oligomerizes with the CC chemokine receptor CCR5. DARC-CCR5 interaction impairs chemotaxis and calcium flux through CCR5, whereas internalization of CCR5 in response to ligand binding remains unchanged. These results suggest a novel mechanism by which DARC could modulate inflammatory responses to chemokines in vivo.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18230715     DOI: 10.1124/mol.107.040915

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  36 in total

1.  A recombinant dromedary antibody fragment (VHH or nanobody) directed against human Duffy antigen receptor for chemokines.

Authors:  Dorota Smolarek; Claude Hattab; Gholamreza Hassanzadeh-Ghassabeh; Sylvie Cochet; Carlos Gutiérrez; Alexandre G de Brevern; Rachanee Udomsangpetch; Julien Picot; Magdalena Grodecka; Kazimiera Wasniowska; Serge Muyldermans; Yves Colin; Caroline Le Van Kim; Marcin Czerwinski; Olivier Bertrand
Journal:  Cell Mol Life Sci       Date:  2010-05-11       Impact factor: 9.261

Review 2.  Mechanisms regulating chemokine receptor activity.

Authors:  Laura D Bennett; James M Fox; Nathalie Signoret
Journal:  Immunology       Date:  2011-11       Impact factor: 7.397

Review 3.  Modulation of chemokine receptor activity through dimerization and crosstalk.

Authors:  C L Salanga; M O'Hayre; T Handel
Journal:  Cell Mol Life Sci       Date:  2009-04       Impact factor: 9.261

Review 4.  In silico studies on DARC.

Authors:  Alexandre G de Brevern; Ludovic Autin; Yves Colin; Olivier Bertrand; Catherine Etchebest
Journal:  Infect Disord Drug Targets       Date:  2009-06

5.  Regulation of motor function and behavior by atypical chemokine receptor 1.

Authors:  Erich H Schneider; Stephen C Fowler; Michail S Lionakis; Muthulekha Swamydas; Gibran Holmes; Vivian Diaz; Jeeva Munasinghe; Stephen C Peiper; Ji-Liang Gao; Philip M Murphy
Journal:  Behav Genet       Date:  2014-07-06       Impact factor: 2.805

Review 6.  Chemokine receptor oligomerization and allostery.

Authors:  Bryan Stephens; Tracy M Handel
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

7.  Application of G protein-coupled receptor-heteromer identification technology to monitor β-arrestin recruitment to G protein-coupled receptor heteromers.

Authors:  Heng B See; Ruth M Seeber; Martina Kocan; Karin A Eidne; Kevin D G Pfleger
Journal:  Assay Drug Dev Technol       Date:  2010-12-06       Impact factor: 1.738

8.  Inhibition of CXCR3-mediated chemotaxis by the human chemokine receptor-like protein CCX-CKR.

Authors:  J Vinet; M van Zwam; I M Dijkstra; N Brouwer; H R J van Weering; A Watts; M Meijer; M R Fokkens; V Kannan; D Verzijl; H F Vischer; M J Smit; R Leurs; K Biber; H W G M Boddeke
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

9.  Identification of a domain critical for Staphylococcus aureus LukED receptor targeting and lysis of erythrocytes.

Authors:  Marilyn T Vasquez; Ashira Lubkin; Tamara Reyes-Robles; Christopher J Day; Keenan A Lacey; Michael P Jennings; Victor J Torres
Journal:  J Biol Chem       Date:  2020-10-13       Impact factor: 5.157

10.  CCR5 signalling, but not DARC or D6 regulatory, chemokine receptors are targeted by herpesvirus U83A chemokine which delays receptor internalisation via diversion to a caveolin-linked pathway.

Authors:  Julie Catusse; David J Clark; Ursula A Gompels
Journal:  J Inflamm (Lond)       Date:  2009-07-30       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.